As a Result of the Jupiter Trial, 65 Percent of Surveyed MCO Pharmacy Directors Will Reimburse Crestor for Patients with Elevated hsCRP

Percentage of Clinicians Performing hsCRP Testing Will Increase Dramatically Over the Next Six Months, According to a New Report from Decision Resources WALTHAM, Mass., Feb. 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and he...

Surveyed Physicians Will Treat Over 50 Percent of Hepatitis C Genotype 1-Infected Patients With the Protease Inhibitor Telaprevir

...pact of and Receptivity to Novel Antivirals Among Payers and Prescribers is based on a U.S. survey of 84 gastroenterologists, 16 hepatologists and 20 mco pharmacy directors. Their responses were compared to assess similarities and differences of opinion regarding clinical, economic and scientific factor...

EDI Health Group Continues to Drive Growth of EDI Processing Services in the Dental Healthcare Industry Through Addition of 25 New Connections in the First Half of 2009

...lth Services, Wisconsin State Employees Maryland Physicians Care, mco Medicaid of Georgia, Grady HealthCare, Inc. Medicaid of Maryland, Physicians Care mco Medicaid of Missouri, Blue Advantage, Community Health Plan, Firs...

Surveyed Oncologists Expect to Prescribe Provenge to about Half of Their Prostate Cancer Patients if the Vaccine is Approved

...itudes Toward Emerging Cancer Vaccines for Prostate Cancer, Lung Cancer, and Glioma is based on a U.S. survey of 70 oncologists, 71 urologists and 20 mco pharmacy directors. Their responses were compared to assess similarities and differences of opinion regarding clinical, economic and scientific factor...

For Treatment of Type 2 Diabetes, 89 Percent of Surveyed Endocrinologists Identify a Need for Additional GLP-1 Analogues and 71 Percent Say the Same About DPP-IV Inhibitors

...et: Is There Room for New GLP-1 Analogues or DPP-IV Inhibitors? is based on a U.S. survey of 77 primary care physicians, 72 endocrinologists and 20 mco pharmacy directors. Their responses were compared to assess similarities and differences of opinion regarding clinical, economic and scientific factor...

For Treatment of Dyslipidemia, Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials

... to have left an incorrect and unfavorable impression about Vytorin on many mco pharmacy directors." Vytorin One Year On: How Will Prescriber Attitud...sed on a U.S. survey of 70 primary care physicians, 70 cardiologists and 20 mco pharmacy directors. Their responses were compared to assess similarities an...

As a Result of the FDA Investigation Into TNF-Alpha Inhibitors, 30 Percent of Surveyed Rheumatologists Have Altered Their Prescription Patterns for Juvenile Idiopathic Arthritis

... Twenty Percent of Surveyed mco Pharmacy Directors Say They Will Alter Reimbursement of TNF-alpha Inhibitor... arthritis and pediatric Crohn's disease. "Twenty percent of surveyed mco pharmacy directors will alter their reimbursement of TNF-alpha inhibitors f...

Amilpar - Revenues Increase by 26.5% and Adjusted Net Income Climbs 28.7% in 2008

...11) 2188-0188 Code: Amil Webcast: www.amilpar.com.br/ri About Amilpar Amil Participacoes S.A. ( Bovespa: AMIL3 ) is the largest mco (managed care organization) in Brazil, serving more than 3.2 million members in the States of Sao Paulo, Rio de Janeiro, Parana and Distrito Federal. ...

Amilpar - Notice to Shareholders - Distribution of Interest on Capital Stock

... www.amilpar.com.br/ir About Amilpar Amil Participacoes S.A. (Bovespa: AMIL3; Bloomberg: AMIL3 BZ; Reuters: AMIL3.SA) is the largest mco (managed care organization) in Brazil, serving more than 3.1 million members in the States of Sao Paulo, Rio de Janeiro, Parana and Distrito Federal. ...

AMERIGROUP Community Care of Ohio Awarded New Health Plan Accreditation From NCQA

...mbers. NCQA's New Health Plan Accreditation Program applies to health plans that are fewer than 36 months old and is distinct from the organization's mco Accreditation Program. AMERIGROUP Community Care of Ohio is a wholly owned subsidiary of AMERIGROUP Corporation. NCQA has also accredited AMERIG...

MCO in Medical Technology

Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer

...for coverage of virtually all anti-tumor agents. According to the report, mco pharmacy directors commonly cite insufficient clinical benefit over cheaper...ian and Payer Attitudes is based on a U.S. survey of 100 oncologists and 20 mco pharmacy directors. Their responses were compared to assess similarities an...

MCO in Biological Technology

Half of Surveyed Physicians Expect to Replace Between 6 Percent and 15 Percent of Their Sustiva Prescriptions with Isentress

... Most Surveyed mco Pharmacy Directors Do Not Place Cost Control Measu...xt 12 months, according to more than 80 percent of mco pharmacy directors surveyed. The report also fin...urvey of 103 infectious disease specialists and 20 mco pharmacy directors. Their responses were compared ...